Pharmacists in Port Chester, New York


13 Pharmacists found in Port Chester
female pharmacist

Blessy Rajan, PHARM D


Pharmacist
107 N Main St, Port Chester, NY 10573
914-934-1580    

female pharmacist

Cynthia Chisom Mgbeojirikwe


Pharmacist
107 N Main St, Port Chester, NY 10573
914-934-1580     914-934-1586

male pharmacist

Daniel Harris Stern, RPH


Pharmacist
130 Midland Ave, Port Chester, NY 10573
914-937-0996     914-937-5015



female pharmacist

Jasjit Kaur Singh, R.PH


Pharmacist
1 Westchester Ave, Port Chester, NY 10573
914-935-3102    

female pharmacist

Dr. Laura Cacioppo, PHARMD


Pharmacist
25 Waterfront Pl, Port Chester, NY 10573
914-937-7452    

male pharmacist

Dr. Md Mahiuddin Bhuiyan, PHARMD


Pharmacist
107 N Main St, Port Chester, NY 10573
914-934-1850    

male pharmacist

Dr. Mohammed Naeem Khan, PHARM.D.


Pharmacist
1 Westchester Ave, Port Chester, NY 10573
914-935-3102     914-935-3120

male pharmacist

Nicholas Saselu, RPH


Pharmacist
25 Waterfront Pl, Port Chester, NY 10573
914-937-7452     914-937-7894

female pharmacist

Oludolapo Arowolo


Pharmacist
120 N Pearl St Apt 311, Port Chester, NY 10573
347-536-8942    

male pharmacist

Patrick Cen


Pharmacist
25 Waterfront Pl, Port Chester, NY 10573
914-937-7452    

female pharmacist

Ms. Suzanne Glassman, RPH


Pharmacist
107 N Main St, Port Chester, NY 10573
914-934-1580    

female pharmacist

Svetlana Margules, RPH


Pharmacist
1 Westchester Ave, Port Chester, NY 10573
914-935-3102    

female pharmacist

Wei Kuan Chan


Pharmacist
25 Waterfront Pl, Port Chester, NY 10573
914-937-7452     914-937-7894


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.